314 related articles for article (PubMed ID: 23391724)
1. SHP-1 phosphatase activity counteracts increased T cell receptor affinity.
Hebeisen M; Baitsch L; Presotto D; Baumgaertner P; Romero P; Michielin O; Speiser DE; Rufer N
J Clin Invest; 2013 Mar; 123(3):1044-56. PubMed ID: 23391724
[TBL] [Abstract][Full Text] [Related]
2. Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes.
Duong MN; Erdes E; Hebeisen M; Rufer N
J Immunother Cancer; 2019 Nov; 7(1):284. PubMed ID: 31690351
[TBL] [Abstract][Full Text] [Related]
3. Human leucocyte antigen class I-redirected anti-tumour CD4
Tan MP; Dolton GM; Gerry AB; Brewer JE; Bennett AD; Pumphrey NJ; Jakobsen BK; Sewell AK
Clin Exp Immunol; 2017 Jan; 187(1):124-137. PubMed ID: 27324616
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of SHP-1 Expands the Repertoire of Antitumor T Cells Available to Respond to Immune Checkpoint Blockade.
Snook JP; Soedel AJ; Ekiz HA; O'Connell RM; Williams MA
Cancer Immunol Res; 2020 Apr; 8(4):506-517. PubMed ID: 32075800
[TBL] [Abstract][Full Text] [Related]
5. Evidence for a TCR affinity threshold delimiting maximal CD8 T cell function.
Schmid DA; Irving MB; Posevitz V; Hebeisen M; Posevitz-Fejfar A; Sarria JC; Gomez-Eerland R; Thome M; Schumacher TN; Romero P; Speiser DE; Zoete V; Michielin O; Rufer N
J Immunol; 2010 May; 184(9):4936-46. PubMed ID: 20351194
[TBL] [Abstract][Full Text] [Related]
6. Fine-Tuning of Optimal TCR Signaling in Tumor-Redirected CD8 T Cells by Distinct TCR Affinity-Mediated Mechanisms.
Presotto D; Erdes E; Duong MN; Allard M; Regamey PO; Quadroni M; Doucey MA; Rufer N; Hebeisen M
Front Immunol; 2017; 8():1564. PubMed ID: 29187853
[TBL] [Abstract][Full Text] [Related]
7. Sodium stibogluconate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines.
Pathak MK; Yi T
J Immunol; 2001 Sep; 167(6):3391-7. PubMed ID: 11544330
[TBL] [Abstract][Full Text] [Related]
8. Loss of Src homology region 2 domain-containing protein tyrosine phosphatase-1 increases CD8+ T cell-APC conjugate formation and is associated with enhanced in vivo CTL function.
Sathish JG; Dolton G; Leroy FG; Matthews RJ
J Immunol; 2007 Jan; 178(1):330-7. PubMed ID: 17182570
[TBL] [Abstract][Full Text] [Related]
9. Docking protein Gab2 is phosphorylated by ZAP-70 and negatively regulates T cell receptor signaling by recruitment of inhibitory molecules.
Yamasaki S; Nishida K; Hibi M; Sakuma M; Shiina R; Takeuchi A; Ohnishi H; Hirano T; Saito T
J Biol Chem; 2001 Nov; 276(48):45175-83. PubMed ID: 11572860
[TBL] [Abstract][Full Text] [Related]
10. The Src-homology domain 2-bearing protein tyrosine phosphatase-1 inhibits antigen receptor-induced apoptosis of activated peripheral T cells.
Zhang J; Somani AK; Watt S; Mills GB; Siminovitch KA
J Immunol; 1999 Jun; 162(11):6359-67. PubMed ID: 10352248
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel lipid raft-targeting motif in Src homology 2-containing phosphatase 1.
Sankarshanan M; Ma Z; Iype T; Lorenz U
J Immunol; 2007 Jul; 179(1):483-90. PubMed ID: 17579069
[TBL] [Abstract][Full Text] [Related]
12. Positive and negative regulation of high affinity IgE receptor signaling by Src homology region 2 domain-containing phosphatase 1.
Nakata K; Yoshimaru T; Suzuki Y; Inoue T; Ra C; Yakura H; Mizuno K
J Immunol; 2008 Oct; 181(8):5414-24. PubMed ID: 18832698
[TBL] [Abstract][Full Text] [Related]
13. Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression.
Poncette L; Chen X; Lorenz FK; Blankenstein T
J Clin Invest; 2019 Jan; 129(1):324-335. PubMed ID: 30530988
[TBL] [Abstract][Full Text] [Related]
14. Carcinoembryonic antigen-related cell adhesion molecule 1 inhibits proximal TCR signaling by targeting ZAP-70.
Chen Z; Chen L; Qiao SW; Nagaishi T; Blumberg RS
J Immunol; 2008 May; 180(9):6085-93. PubMed ID: 18424730
[TBL] [Abstract][Full Text] [Related]
15. A rare population of tumor antigen-specific CD4
Matsuzaki J; Tsuji T; Chodon T; Ryan C; Koya RC; Odunsi K
J Immunother Cancer; 2019 Jan; 7(1):7. PubMed ID: 30626427
[TBL] [Abstract][Full Text] [Related]
16. Interplay between T cell receptor binding kinetics and the level of cognate peptide presented by major histocompatibility complexes governs CD8+ T cell responsiveness.
Irving M; Zoete V; Hebeisen M; Schmid D; Baumgartner P; Guillaume P; Romero P; Speiser D; Luescher I; Rufer N; Michielin O
J Biol Chem; 2012 Jun; 287(27):23068-78. PubMed ID: 22549784
[TBL] [Abstract][Full Text] [Related]
17. CD5 negatively regulates the T-cell antigen receptor signal transduction pathway: involvement of SH2-containing phosphotyrosine phosphatase SHP-1.
Perez-Villar JJ; Whitney GS; Bowen MA; Hewgill DH; Aruffo AA; Kanner SB
Mol Cell Biol; 1999 Apr; 19(4):2903-12. PubMed ID: 10082557
[TBL] [Abstract][Full Text] [Related]
18. The phosphotyrosine phosphatase SHP-2 participates in a multimeric signaling complex and regulates T cell receptor (TCR) coupling to the Ras/mitogen-activated protein kinase (MAPK) pathway in Jurkat T cells.
Frearson JA; Alexander DR
J Exp Med; 1998 May; 187(9):1417-26. PubMed ID: 9565634
[TBL] [Abstract][Full Text] [Related]
19. PD-1 is a regulator of NY-ESO-1-specific CD8+ T cell expansion in melanoma patients.
Fourcade J; Kudela P; Sun Z; Shen H; Land SR; Lenzner D; Guillaume P; Luescher IF; Sander C; Ferrone S; Kirkwood JM; Zarour HM
J Immunol; 2009 May; 182(9):5240-9. PubMed ID: 19380770
[TBL] [Abstract][Full Text] [Related]
20. Involvement of the SHP-1 tyrosine phosphatase in regulation of T cell selection.
Zhang J; Somani AK; Yuen D; Yang Y; Love PE; Siminovitch KA
J Immunol; 1999 Sep; 163(6):3012-21. PubMed ID: 10477564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
